The Liver Center at University Gastroenterology is under the leadership of Dr. Thomas Sepe and Dr. Eric Newton. The Liver Center provides the latest in state-of-the-art care for all forms of liver disease, including Hepatitis B and C, cirrhosis and its complications, hereditary liver disease, and fatty liver/steatohepatitis. The Research Unit of the Liver Center under the direction of Dr. Sepe as Principal Investigator has conducted over 90 clinical trials in liver disease. Many of the latest treatments leading to cure in Hepatitis C have been developed at the Center, and its staff are expert in their usage. Current trials are focusing on agents effective for the treatment of steatohepatitis and the therapy and reversal of cirrhosis and well as even better therapies for Hepatitis C.
The Liver Center features FIBROscan, an FDA approved device for the noninvasive assessment of liver fibrosis and cirrhosis; it is the only device of its kind in clinical practice within 50 miles. The physicians of University Gastroenterology are happy to accept referrals in liver disease from physicians in Rhode Island and throughout Southeastern New England. University Gastroenterology evaluates patients on four main campuses with satellite offices located throughout the State of Rhode Island. It is a major affiliate of UNIVERSITY ENDOSCOPY GROUP, composed of four state- of- the- art outpatient ambulatory endoscopy centers.
The Liver Center at University Gastroenterology is under the leadership of Dr. Thomas Sepe and Dr. Eric Newton. The Liver Center provides the latest in state-of-the-art care for all forms of liver disease, including Hepatitis B and C, cirrhosis and its complications, hereditary liver disease, and fatty liver/steatohepatitis. The Research Unit of the Liver Center under the direction of Dr. Sepe as Principal Investigator has conducted over 90 clinical trials in liver disease. Many of the latest treatments leading to cure in Hepatitis C have been developed at the Center, and its staff are expert in their usage. Current trials are focusing on agents effective for the treatment of steatohepatitis and the therapy and reversal of cirrhosis and well as even better therapies for Hepatitis C.
The Liver Center features FIBROscan, an FDA approved device for the noninvasive assessment of liver fibrosis and cirrhosis; it is the only device of its kind in clinical practice within 50 miles. The physicians of University Gastroenterology are happy to accept referrals in liver disease from physicians in Rhode Island and throughout Southeastern New England. University Gastroenterology evaluates patients on four main campuses with satellite offices located throughout the State of Rhode Island. It is a major affiliate of UNIVERSITY ENDOSCOPY GROUP, composed of four state- of- the- art outpatient ambulatory endoscopy centers.
Thomas E. Sepe, M.D. – Director
Eric Newton, M.D. – Associate Director
Ravi Nadimpalli, M.D. - Staff Physician
Jeff Nadelson, M.D.- Staff Physician
Brandie Millovitsch, R.N. – Research Coordinator
Liver Conditions
Video: What is NASH?
Video: University Gastroenterology's Liver Team Discusses Hepatitis C